missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Invitrogen™ Digoxin Monoclonal Antibody (DG D8-9), Invitrogen™

Invitrogen™ Digoxin Monoclonal Antibody (DG D8-9), Invitrogen™

Product Code. 17880466
Change view
Click to view available options
Quantity:
1 mg
100 μg
500 μg
Unit Size:
100µg
1mg
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
17880466 100 μg 100µg
11513423 500 μg 1mg
17820476 1 mg 1mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
This item is not returnable. View return policy
Product Code. 17880466 Supplier Invitrogen™ Supplier No. MA546140

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Mouse Monoclonal Antibody

MA1-10809 detects Digoxin. MA1-10809 has been successfully used in ELISA applications. The MA1-10809 immunogen is Digoxin, conjugated to KLH.

Digoxin is a beta blocker drug used to treat heart problems, such as heart failure, high blood pressure.
TRUSTED_SUSTAINABILITY

Specifications

Antigen Digoxin
Applications ELISA
Classification Monoclonal
Clone DG D8-9
Concentration 0.80 mg/mL
Conjugate Unconjugated
Formulation PBS with no preservative; pH 7.4
Gene Alias C41H64O14; DGX; Lanoxin
Host Species Mouse
Immunogen Digoxin, conjugated to KLH.
Purification Method Protein G
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Chemical
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Liquid
Isotype IgG1
Target Molecule Chemical
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.